IL6 and COVID-19: Upon admission, male patients with acute COVID-19 exhibited high levels of circulating IL-6 (139.28 ± 48.95 ng/mL), which significantly decreased following the administration of 1α,25(OH)2D3 (2.65 ± 0.92 ng/mL).